The DOPPS Program includes three large cohort studies with goal to identify optimal practices for patients with advanced CKD or kidney failure. The program is active at over 750 clinical sites in twenty countries, and it has a wide network of scientific collaborators with more than 300 scientific publications. Dr. Robinson is Co-Principal Investigator of the Data Coordinating Center for the Cure Glomerulonephopathy Research Network (CureGN), an NIH/NIDDK-funded multi-center cohort study of patients with glomerular disease (ongoing, since 2013). He has research expertise in the epidemiology of kidney disease and quantitative analysis for studies of patients with advanced CKD and kidney failure.